Aster-QCIL Pledges ₹1,661 Crore Investment to Strengthen Kerala’s Healthcare Network

IMT News Desk
IMT News Desk
· 2 min read
Aster DM Healthcare and QCIL announce a ₹1,661 crore investment to expand Kerala’s healthcare capacity, beds, jobs and cancer care initiatives.

Aster DM Healthcare’s Founder & Chairman, Dr. Azad Moopen, met Kerala’s Chief Minister and welcomed the State’s progressive budget, saying it reflects a strong focus on healthcare, education, employment, infrastructure and social development. During the meeting, he reaffirmed Aster’s long-term commitment to Kerala and discussed ways to expand healthcare infrastructure, medical education, skill development, medical tourism, healthcare technology and charitable initiatives across the State.

Dr. Moopen said Kerala holds a special place in Aster’s journey and remains one of its most strategic markets. He noted that the State’s skilled doctors, nurses and allied healthcare professionals give it a strong advantage in building a leading healthcare ecosystem. He said Aster remains committed to supporting Kerala’s vision of becoming one of India’s top healthcare destinations.

Following the integration of Aster and Quality Care India Ltd (QCIL), the combined network will operate 11 hospitals in Kerala with 4,575 beds, creating one of the country’s strongest healthcare platforms for tertiary and quaternary care. The group also plans to invest an additional ₹1,661 crore in Kerala to add 1,315 beds over the coming years, while creating nearly 7,900 additional jobs.

Aster said it will add 834 beds in Kerala on its own, including the upcoming 454-bed Aster Hospital in Thiruvananthapuram. The expansion is expected to strengthen access to advanced healthcare services, especially in South Kerala.

Dr. Moopen also underlined Aster’s commitment to charity and community care, noting the role of Aster Volunteers in relief and rehabilitation efforts after the Chooralmala-Mundakkai landslide disaster in Wayanad. He said the group remains focused on supporting vulnerable communities through healthcare, education and social welfare initiatives.

He further highlighted Aster’s ₹120 crore Cancer Care CSR Programme, under which advanced cancer treatment facilities will be developed across India over the next three years. The first project under the initiative is a state-of-the-art Linear Accelerator facility in Wayanad, aimed at making radiation therapy more accessible for patients from underserved regions.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk